{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-014316","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2023-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.880670+00:00","generated_at":"2026-06-19T00:27:55.932192+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"China Pharma Holdings announces 1-for-10 reverse stock split effective March 6, 2023","bullets":["Reverse stock split at 1-for-10 ratio, effective March 6, 2023, trading begins on split-adjusted basis at market open.","Every 10 existing shares convert into 1 share; fractional shares rounded up to whole number.","Approved by Board and stockholders at Annual Meeting on December 27, 2022.","Trading symbol remains 'CPHI' on NYSE American; new CUSIP number 16941T-203.","Reverse stock split does not alter any stockholder's percentage interest except for fractional share adjustments."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-014316","json":"https://secwatch.observer/filing/0001213900-23-014316.json","markdown":"https://secwatch.observer/filing/0001213900-23-014316.md","text":"https://secwatch.observer/filing/0001213900-23-014316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390023014316/0001213900-23-014316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390023014316/ea174228-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T00:27:55.932192+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}